Arrowstreet Capital Limited Partnership Increases Position in Tenet Healthcare Corporation $THC

Arrowstreet Capital Limited Partnership raised its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 57.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 671,700 shares of the company’s stock after purchasing an additional 244,901 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Tenet Healthcare were worth $126,757,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Baron Wealth Management LLC lifted its holdings in shares of Tenet Healthcare by 4.8% in the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after buying an additional 52 shares during the period. PeakShares LLC raised its holdings in shares of Tenet Healthcare by 3.3% in the first quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after acquiring an additional 54 shares in the last quarter. Sanctuary Advisors LLC lifted its stake in Tenet Healthcare by 0.5% in the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after acquiring an additional 57 shares during the period. Quadrant Capital Group LLC grew its holdings in Tenet Healthcare by 0.7% during the 4th quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after acquiring an additional 58 shares in the last quarter. Finally, Applied Finance Capital Management LLC increased its position in Tenet Healthcare by 3.8% during the 1st quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after purchasing an additional 60 shares during the period. Institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Royal Bank Of Canada decreased their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. KeyCorp cut their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Wells Fargo & Company lifted their price target on Tenet Healthcare from $213.00 to $231.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Barclays boosted their price target on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Robert W. Baird reduced their target price on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Seventeen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $246.47.

Trending Headlines about Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet’s Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

Insider Activity

In related news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.97% of the company’s stock.

Tenet Healthcare Stock Up 17.1%

Shares of NYSE THC opened at $233.10 on Friday. The stock has a market cap of $20.08 billion, a PE ratio of 8.99, a price-to-earnings-growth ratio of 1.93 and a beta of 1.27. The business has a 50-day moving average price of $185.16 and a 200 day moving average price of $197.62. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 27.17%. Tenet Healthcare’s revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $4.02 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 21 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.